Abstract: Novel classes of synthetic drugs, including synthetic cathinones (''bath salts'') and synthetic cannabinoids (''spice'' or ''K2''), have recently emerged as popular drugs of abuse. Salvia divinorum, a naturally occurring herb, has gained popularity in the last decade as a hallucinogenic as well. The legal status of these substances has been undergoing rapid changes and has been confusing to lawmakers and medical practitioners alike. We present an up-to-date information about the legality of these substances. We also discuss the historical background, chemical composition, patterns of abuse, clinical presentations, laboratory analysis, and management strategies for these drugs, with an emphasis on synthetic cathinones. 
TARGET AUDIENCE
This continuing medical education activity is intended for physicians, nurse practitioners, physician assistants, and emergency medical services personnel who care for children and adolescents in the prehospital, emergency, or primary care settings. Specialists including pediatricians, emergency physicians, pediatric emergency physicians, family practitioners, and pediatric nurse practitioners will find this information particularly useful.
LEARNING OBJECTIVES
After completion of this article, the reader should be able to: 1. Identify the pharmacology, legal status, and emergence patterns of synthetic cathinones. 2. Evaluate and manage patients with suspected intoxication of bath salts. 3. Identify characteristics of other emerging toxins such as synthetic cannabinoids and Salvia divinorum.
BACKGROUND
Novel classes of synthetic drugs, including synthetic cathinones or ''bath salts,'' have recently emerged as popular drugs of abuse. In 2009 and 2010, the abuse of synthetic cathinones became a concern in western Europe, and these substances first appeared in the United States in 2010.
1, 2 The US poison control centers began receiving calls regarding bath salts in December of 2010. 2 Although the legal status of these synthetic drugs has been undergoing rapid change (see Legal Status section), there was a drastic increase in bath salt use in 2011 because of the widespread availability and media sensation surrounding these substances.
Synthetic cathinones have been sold over the Internet and at gas stations, convenience stores, head shops (stores that sell drugrelated paraphernalia), and smoke shops. To circumvent drug abuse legislation, they have been labeled as ''not for human consumption'' and sold as bath salts, plant food, and various other pseudonyms. 1, 3 Most commonly called bath salts, these substances have a variety of other street names, including bloom, blue silk, charge+, hurricane Charlie, ivory snow, ivory wave, lunar wave, ocean burst, ocean snow, pure ivory, purple wave, red dove, scarface, sextacy, snow leopard, stardust, vanilla sky, white dove, white knight, white lightning, white rush, and zoom.
2Y4
Although they have garnered the most media attention, synthetic cathinones are not the only manufactured substances that have seen a recent increase in use. Synthetic cannabinoids, most commonly known as ''spice'' or ''K2,'' have also become popular drugs of abuse. Recreational users have turned to synthetic drugs for a number of reasons. The easy availability of the product has certainly contributed. Because the legality of synthetic substances had not, until recently, been established, the consumers thought that they could get ''legal highs'' without the risk of prosecution. 3 Furthermore, commonly used serum and urine drug screens are not yet routinely available for synthetic drugs, making them more difficult to detect in an intoxicated individual or someone who must undergo drug testing. 5Y7 Another reason for the popularity of synthetic drugs has been the relative affordability of these substances, particularly when compared with their illegal counterparts. 5 Marketing the products as bath salts or ''plant food'' may provide users with false reassurance about the safety of these products. 5 Finally, the purity of synthetic cathinones and cannabinoids has been shown to be preferred over their natural alternatives, such as cocaine, ecstasy, and marijuana, which have become increasingly impure in recent years. 8 
From Natural to Synthetic Cathinones
Cathinones are phenylalkylamine alkaloids (A-ketone amphetamine analogs) naturally present in the leaves and stems of the khat plant (Catha edulis).
1,9,10 Catha edulis is a slowgrowing shrub native to Ethiopia and cultivated in East Africa and the southwest Arabian Peninsula. 10 The practice of chewing the leaves of this plant for its resultant psychostimulant and euphoric effects has been known in these parts of the world for hundreds of years, and it was first described in the medical literature in the 11th century. 11, 12 Today, chewing the leaves for stimulant purposes is popular in certain Middle Eastern countries, particularly in Yemen. 13 In 2006, there were an estimated 10 million daily khat users worldwide. 14, 15 Like amphetamines, cathinone is a central nervous system stimulant, but its potency is less. 5 Clinical data have shown that it can cause an increase in heart rate and blood pressure, euphoria, alertness, and psychomotor hyperactivity. 9 However, several studies have illustrated the negative effects of khat chewing, which include hypertension, myocardial infarction from acute coronary vasospasm, esophagitis, gastritis, liver toxicity, insomnia, depression, anorexia, psychosis, impaired memory, and a withdrawal syndrome.
16Y18
Synthesis of cathinone derivatives was first reported in the 1920s, with methcathinone being synthesized in 1928 and mephedrone in 1929. 19, 20 Derivatives have been investigated for medical use, but most were ultimately unsuccessful because of severe side effect profiles. 1 Bupropion, which is currently prescribed for the treatment of depression and as a smokingcessation aid, is the only cathinone derivative that carries a medical indication in the United States and in Europe. 1, 21 It is unclear exactly when synthetic cathinones first gained popularity among recreational drug users, but mention of such use on Internet forums dates back to 2007. 22 Synthetic cathinones are phenylalkylamine derivatives that contain a ketone at the A position on the amino alkyl chain attached to the phenyl ring and are therefore known as bk-amphetamines. 23 As a class, the stimulant effects of synthetic cathinones have been compared with those of methylphenidate at low doses and cocaine or amphetamines at high doses. 5 Similar to amphetamines, these substances cause stimulant effects by increasing the concentration of catecholamines, such as dopamine, serotonin, and norepinephrine, in synapses. 5 Synthetic cathinones are generally less potent than amphetamines at similar doses because the A-keto group increases polarity and renders the compounds less able to cross the blood-brain barrier. 5 Although there is an ongoing investigation, little is known about the exact metabolism of synthetic cathinones. 6 Most seem to be metabolized by liver cells and excreted in the urine. 5, 6 Although the number of different synthetic cathinones is immense and ever growing, there are some that have been at the forefront of both media coverage and medical reports. The 3 substances that have garnered the most attention are MDPV (3,4-methylenedioxypyrovalerone), methylone (3,4-methylenedioxy-N-methylcathinone), and mephedrone (4-methylmethcathinone). Thus it was these 3 specific substances that were temporarily placed under Schedule I of the Controlled Substances Act in the fall of 2011. Mephedrone has been the most widely used synthetic cathinone in Europe, whereas MDPV is the most prevalent in the United States. 3 
Legal Status
The legal status of synthetic drugs is variable by country and has been undergoing rapid change. Lawmakers in the United States have taken action to try to slow the rapid spread of synthetic cathinone and cannabinoid use. On September 21, 2011, the Drug Enforcement Administration (DEA) used its emergency scheduling authority to enact temporary control over synthetic cathinones. This made the possession or sale of mephedrone, MDPV, and methylone illegal for 1 year, while further evaluation was conducted to determine the need for permanent control. 1, 4 These substances were thus placed under Schedule I of the Controlled Substances Act, meaning that they were determined to have no accepted medical use in the United States and a high potential for abuse. 24 Because of chemists' ability to rapidly alter the molecular components of synthetic cathinones, thereby creating new and different drugs, control of these substances remained difficult. On July 9, 2012, President Obama signed into law the Synthetic Drug Abuse Prevention Act of 2012 as part of Senate Bill 3187, the Food and Drug Administration Safety and Innovation Act. 25 This act ''amends the Controlled Substances Act to add as a Schedule I controlled substance: (1) any material, compound, mixture, or preparation which contains specified cannabimimetic agents (or the salts, isomers, or salts of isomers thereof ); and (2) specified additional hallucinogenic substances.'' 26 This verbiage was selected in an attempt to broaden the spectrum of substances classified under Schedule I and to prevent minor alterations in molecular makeup from allowing the drugs to maintain legality.
Patterns and Methods of Abuse
Although synthetic cathinones remain a public health concern, recent data show that the incidence of use may have already peaked. According to the American Association of Poison Control Centers, calls about human exposure to bath salts began at the end of 2010 with 310 calls reported. The incidence peaked in 2011, when 6138 calls about synthetic cathinones were received (peak: June 2011, 743 calls). Data from 2012 show that as of September 30, reports of 2363 human exposures had been received. 27 It is noteworthy that although the peak incidence of synthetic cathinone use has been seen in ages 20 to 29 years, American poison control centers have received reports of exposure in children as young as 6 years. 27 Furthermore, a survey of high school and college students in the United Kingdom illustrated that 20% had used mephedrone at least once. Daily use of this substance was reported in 4% of those surveyed, all of whom were younger than 21 years. Clinicians working in emergency medicine should thus have an understanding of these drugs to appropriately manage adolescent patients with potential synthetic cathinone intoxication.
Synthetic cathinones are most commonly nasally insufflated or ingested. 28, 29 Insufflation is sometimes facilitated by ''keying,'' a practice in which a key is dipped into the powder, which is then snorted from the surface of the key. 21 Another common practice is ''bombing,'' during which the synthetic cathinone is wrapped in cigarette paper and then orally ingested. 30 Less common methods of use include rectal or gingival administration, inhalation, and intramuscular or intravenous injection. 2, 30, 31 Often several routes of administration are used concomitantly in a single session.
1,2,28

Clinical Manifestations
Although investigation of most deaths associated with synthetic cathinones has revealed multiple drugs of abuse, morbidities have been attributed to sole intoxication with mephedrone, methylone, MDPV, and other synthetic substances. 1, 5, 7 The most common clinical manifestations resulting from synthetic cathinone abuse include agitation, confusion, psychosis, tachycardia, and hypertension, which are classic manifestations of a sympathomimetic toxidrome. 1, 2 Other commonly reported symptoms are chest pain, palpitations, fever, hyperthermia, nausea, vomiting, diaphoresis, abdominal pain, dyspnea, headache, and seizures. 1Y3,29,31Y34 There are less common but potentially detrimental adverse effects of synthetic cathinones that have been reported. Multiple cases of death resulting from cerebral edema and brainstem herniation secondary to hyponatremia have been reported. 35, 36 The pathophysiologic mechanism leading to hyponatremia in these patients has not been established. Myocarditis can also result from synthetic cathinone abuse, although fortunately this has not directly caused any deaths in the reported literature. 37 Another rare but life-threatening complication is necrotizing fasciitis, which has been reported with intramuscular injection of synthetic cathinones. 38 
Laboratory Evaluation and Management
Because of the increased prevalence of synthetic cathinones, emergency medicine practitioners should maintain a high index of suspicion for these toxins when evaluating a patient presenting with intoxication or overdose. Although certain laboratories are able to detect synthetic cathinones, results demonstrating their presence are not readily available at the time of presentation. No synthetic cathinone derivatives are currently detected on routine drug screens, although their presence may result in a false-positive methamphetamine screen. 14, 39 Proper detection of synthetic cathinones requires commercially available gas chromatography/mass spectrometry or liquid chromatography/ mass spectrometry kits. 5, 14, 39 Given the many aforementioned adverse clinical effects of synthetic cathinone ingestion, there are other laboratory studies that should be strongly considered when evaluating a patient with suspected synthetic cathinone ingestion. Serum and urine toxicologic studies can identify potential coingestions, which is important if the other substance, such as an acetaminophen, requires treatment. A creatine phosphokinase level can help determine if a patient with hyperthermia and muscle rigidity has evidence of rhabdomyolysis. A basic metabolic panel would illustrate signs of resulting renal failure with increased creatinine level and provide sodium and potassium levels, which can alert the practitioner to potential cerebral and cardiac toxicities. In addition, an electrocardiogram and chest radiograph is indicated in a patient with chest pain, tachycardia, or shortness of breath. 40 Treatment of synthetic cathinone overdose is primarily supportive care and symptom control. Most patients are unable to name their specific drug of abuse, but even if they were capable of providing such a history, a specific antidote does not exist. 40 The most common treatments used in emergency departments are intravenous fluids, benzodiazepines, oxygen, and sedatives. 2 Given the similarities of synthetic cathinones to cocaine, amphetamines, and MDMA (3,4-methylenedioxy-N-methylamphetamine), similar treatment strategies should be considered. Patients exhibiting a clinical picture consistent with a sympathomimetic toxidrome should be treated with benzodiazepines to counteract excessive epinephrine and norepinephrine release and reuptake inhibition. 1 As discussed previously, there are other forms of toxicity, such as hyponatremia, myocarditis, and necrotizing fasciitis. 35Y37 Hyponatremia should be corrected slowly with hypertonic saline solutions to avoid central pontine myelinolysis. Suspected necrotizing fasciitis secondary to intramuscular synthetic cathinone injection should be managed with expeditious surgical debridement. 38 
Synthetic Cannabinoids
Herbal marijuana alternatives, most commonly labeled as spice or K2, began emerging as drugs of abuse in the United States in 2008. 14, 41, 42 Commonly marketed as incense or potpourri, they are labeled as not for human consumption to bypass legislation. 14, 43 Many of these herbal mixtures do not have ingredients listed on the packaging. Constituents that are often listed are plant/herbal ingredients such as bay bean, blue lotus, dwarf scullcap, honey, Indian warrior, lion's-tail, lousewart, maconha brava, marshmallow, pink lotus, red clover, rose, Siberian motherwort, and vanilla. 14, 41, 44 When smoked, these products produce effects similar to those of cannabis found in marijuana, but when analyzed, they have not been found to contain tobacco or cannabis. 41 In December of 2008, it was determined that these effects were not entirely the result of herbal components, but that synthetic cannabinoid derivatives comprised part of these mixtures and likely accounted for much of their psychoactive effects. 42, 44, 45 Some common street names for these synthetic cannabinoidcontaining herbal marijuana alternatives other than spice and K2 include albino rhino buds, aroma, barely legal, black mamba, bliss, Damiana, drolle, exclusive cherry, exclusive mint, galaxy, genie, gorilla, halo, k2 summit, krypto buds, red magic, sence, skunk, solar flare, space, spice diamond, spice gold, spice silver, star fire, tai fun, Yucatan fire, zohai, and many more. 14, 42, 46, 47 As was seen with the synthetic cathinone epidemic, synthetic cannabinoids were easily accessed and sold via the Internet and at gas stations, convenience stores, liquor stores, and head shops.
47Y49
In 2009, the cost was significantly cheaper than marijuana, at approximately $40 per 3-g packet. 47 Users of synthetic cannabinoids generally seek legal highs and effects similar to those experienced by smoking marijuana, such as euphoria and relaxation. 46, 49, 50 The primary active ingredient in marijuana is tetrahydrocannabinol (THC), which binds to the endogenous cannabinoid receptors CB 1 and CB 2 .
51 CB 2 receptors are found mostly in peripheral tissue such as blood cells, immune tissues, and spleen, although there are some recent data to suggest that they may exist in the brainstem, cortex, and cerebellum as well.
14,42,52 Their effects are not as well known as those of CB 1 receptors, but they are thought to influence anti-inflammatory and immune-modulating effects through cell migration and release of cytokines. 53, 54 Although not well established, they may also have a role in controlling pain and emesis.
54,55 CB 1 receptors are predominantly found in the central nervous system, densely concentrated in the brain in the cortical and subcortical regions, and in the dorsal root ganglion of the spinal cord. 42, 56 These receptors are responsible for most of the psychoactive components of cannabinoids, as their effects can both elevate a person's mood and inversely induce emotions such as anxiety and panic.
42,57 CB 1 receptors have been shown to have the ability to induce analgesia, relaxation, and euphoria, decrease motor function, impair memory and sense of time, and affect auditory and visual cognition. 42, 58, 59 Importantly, synthetic cannabinoids have demonstrated a higher binding affinity for cannabinoid receptors than THC. 60 Tetrahydrocannabinol is a partial agonist at the CB 1 receptor, whereas all synthetic cannabinoids commonly found in herbal marijuana alternatives are full agonists. 44 As a result, they are more potent than THC and psychoactive doses may be as low as 1 mg or less. 44 This difference is also important because although partial agonists will exhibit a plateau in dose versus clinical response, full agonists have no ceiling on the dose-response relationship and therefore a greater potential for overdose and toxic effects. 45 As a result, users of synthetic cannabinoids frequently require medical attention. 45, 46 Current literature about the clinical effects of synthetic cannabinoid use is mainly in the form of case reports and case series. The most commonly reported adverse effects are tachycardia, agitation, irritability, anxiety, hallucinations, nausea, vomiting, hypertension, confusion, conjunctival injection, and xerostomia.
14,42,45Y47,49,61 More severe complications that have been reported include seizures, psychosis, and supraventricular tachycardia requiring cardioversion. 42, 45, 51 Seizures are thought to result from inhibition of gamma-aminobutyric acid neurotransmission, whereas supraventricular tachycardia may be from an increase in circulating catecholamines or heightened oxidative demands on the myocardium. 51 Because there is no known pharmacologically specific antidote, the management of synthetic cathinone toxicity is supportive care and symptom control.
14 For most patients, it may be sufficient to hydrate and monitor them until vital signs and mental status return to normal. When compared with THC, the half-life and duration of symptoms is longer for some synthetic cannabinoids (CP-47,497) and shorter for others (JWH-018, JWH-073). 50, 51 Benzodiazepines should be used as needed for seizures, agitation, and anxiety. 47, 49 Antipsychotic medications may be helpful in patients with psychosis and behavioral symptoms, prolonged symptoms, or a history of psychotic disorder. 49, 62, 63 Synthetic cannabinoids are not detected on common toxicologic screens that identify THC metabolites.
14,42,47 As a result, these tests are of minimal help to the clinician managing a patient with synthetic cannabinoid intoxication or overdose. Specialized laboratories are able to detect some of the more common synthetic cathinones in blood and urine by using gas chromatography/mass spectrophotometry or liquid chromatography/mass spectrometry methods. 48, 51, 64 Similar to synthetic cathinones, data show that the peak incidence of synthetic cannabinoid use may have passed. Poison control centers received 2906 calls about human exposure to synthetic cannabinoids in 2010. 65 As was seen with synthetic cathinones, 2011 marked the highest use, with 6959 cases reported (peak: July 2011, 705 calls). As of September 30, US poison centers had received 4460 calls in 2012. 65 Studies have shown that adolescents comprise a large part of the synthetic cannabinoidusing population. A report of telephone calls made to Texas poison control centers concerning synthetic cannabinoids in 2010 showed that 40.2% of users were younger than 20 years. 46 Furthermore, data submitted to the US DEA from a major toxicology laboratory indicated that 30% to 35% of the samples from juvenile probation centers from July to November of 2010 tested positive for synthetic cannabinoids. 66 On November 24, 2010, the US DEA temporarily classified 5 common synthetic cannabinoids as Schedule I substances. These included JWH-018; JWH-073; JWH-200; CP-47,497; and cannabicyclohexanol. 67 Similar to the situation with synthetic cathinones, this minimally temporized the illegal use of synthetic cannabinoids. As discussed previously, currently all synthetic cannabinoid derivatives fall under the same illegal category as synthetic cathinones, as specified in the Food and Drug Administration Safety and Innovation Act passed by the US Senate and the House of Representatives. 25, 26 This, in addition to more widespread knowledge about the risks and adverse effects of these substances, may help slow the epidemic of synthetic drug abuse.
Salvia divinorum
Not all emerging toxins are novel and synthetic. Salvia divinorum is an herb native to Mexico that has been used for centuries for its mind-altering effects.
14,68Y70 This species was traditionally used in Mexico by the Mazteca Indians for its potent visionary effects that facilitated spiritual encounters. 68Y71 The active constituent of S. divinorum has been identified as salvinorin A, which accounts for its hallucinogenic properties.
14,72Y74 Common street names include Sally D, diviner's sage, Maria Pastora, SkaPastora, magic mint, mystic sage, purple sticky, and sage of the seers. 14, 69, 71, 74 Salvia divinorum is sold at head shops, gas stations, and via the Internet. 69, 74 The recreational use of S. divinorum by adolescents and young adults has increased over the last decade in the United States, Canada, Europe, and Japan. 14, 73 Desired clinical effects include a ''unique and intense'' high, hallucinations, perceptions of bright lights and vivid colors and shapes, an ''out-ofbody experience,'' and uncontrollable laughter. According to data published in 2008, approximately 1.8 million Americans aged 12 years and older had used S. divinorum in their lifetime, with about 750,000 of those having used the substance in the past year. 74 In addition, the use was more common in those younger than 26 years compared with that in older individuals. 74 , 75 A study of Canadian adolescents aged 12 to 17 years completed in 2009 showed that 6.2% had used S. divinorum in their lifetime, with 3.8% having used the substance in the past year. 73 Unlike the previously mentioned synthetic substances, the American Association of Poison Control Centers does not have data about the number of calls received pertaining to S. divinorum abuse. This is likely in large part due to the chemical properties of salvinorin A. Unlike most hallucinogenic drugs that act on serotonin receptors, salvinorin A acts at the J-opioid receptors in the brain and spinal cord. 76, 77 In the United States, S. divinorum is generally either chewed or, more often, smoked. Both methods can lead to effects within seconds to minutes, with a duration of up to 30 minutes when smoked or 1 hour when absorbed through the buccal mucosa. 14, 74 Because of this short duration, users are less likely to seek medical attention.
Another reason for the relative lack of calls to poison control centers may be related to the relatively benign adverse effect profile of S. divinorum. Although users may describe anxiety, dysphoria, confusion, nausea, and temporary language impairment, there are no characteristic physical findings associated with intoxication from S. divinorum alone.
14,68,72,78 A double-blind, placebo-controlled trial showed that salvinorin A administered to healthy individuals led to hallucinogenic effects but no significant change in heart rate or blood pressure. 78 Because it is uncommon that patients present for medical treatment after exposure to S. divinorum, there are very limited data about the management. There are no known antidotes, although some theorize that naloxone's effects at the J-opioid receptor may have use in reversing neuropsychiatric effects. 14 Recreational users are more likely to present with polysubstance intoxication, and thus supportive care dictated by clinical presentation is a reasonable approach. Benzodiazepines may be helpful with severe agitation.
14 Detection of S. divinorum is almost never needed, but 1 study consisting of 2 volunteers who smoked S. divinorum illustrated that salvinorin A can be detected in urine and saliva using gas chromatography/mass spectrometry. 79 Because S. divinorum is not a synthetic substance, it does not fall under the same Food and Drug Administration Safety and Innovation Act as synthetic cathinones and cannabinoids. 26 Neither S. divinorum nor salvinorin A is currently controlled under the Controlled Substances Act, but it has been labeled a ''drug of concern'' by the US DEA. 74 Several states have enacted legislation placing regulatory controls on these substances, making them illegal to possess or distribute. 74 In addition, S. divinorum and/or salvinorin A have been placed under regulatory controls in Australia, Chile, Japan, and several European countries. 74 
CONCLUSIONS
Although there is evidence to suggest that the peak incidence of synthetic cathinones and cannabinoids has already passed, recent epidemics show us that new emerging toxins will likely pose a public health risk in the future. Naturally occurring substances, such as S. divinorum, are also surfacing as potential drugs of abuse. Relative affordability, easy access, unclear legal status, difficult detectability, and lack of evidence about the dangers of these substances make them attractive for experimentation by adolescents. In addition, diagnostic laboratory studies tend to lag behind these epidemics. It is vital for the clinician to maintain both a basic fund of knowledge and a high index of suspicion when facing clinical toxidromes to manage and monitor patients suspected of intoxication with synthetic cathinones, synthetic cannabinoids, S. divinorum, and future emerging toxins.
This CME activity has summarized the pharmacology, legal status, and emergence patterns of synthetic cathinones, described the characteristics of other emerging toxins, and discussed how to evaluate and manage patients who may suffer from bath salts intoxication.
